TAYSHA GENE THERAPIES, INC. : Other Events, Financial Statements and Exhibits (form 8-K)

Item 8.01 Other Events.

On January 19, 2021, Taysha Gene Therapies, Inc. (the "Company") issued a press release entitled "Taysha Gene Therapies Receives Rare Pediatric Disease Designation and Orphan Drug Designations for TSHA-105 for the Treatment of Epilepsy Caused by SLC13A5 Deficiency." The full text of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits



              Exhibit
                No.                     Description

              99.1        Press release, dated January 19, 2021.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses